Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on January 3, 2020 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
50
Frequently Asked Questions
What is Market Cap of Longboard Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Longboard Pharmaceuticals Inc market cap is $702.56M.
What is the 52-week high for Longboard Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Longboard Pharmaceuticals Inc 52 week high is $28.15 as of June 05, 2024.
What is the 52-week low for Longboard Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Longboard Pharmaceuticals Inc 52 week low is $3.60 as of June 05, 2024.
What is Longboard Pharmaceuticals Inc stock price today?
Longboard Pharmaceuticals Inc stock price today is $18.38.
What was Longboard Pharmaceuticals Inc stock price yesterday?
Longboard Pharmaceuticals Inc stock price yesterday was $18.07.
What is the PE ratio of Longboard Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Longboard Pharmaceuticals Inc’s P/E ratio is -8.01.
What is the Price-to-Book ratio of Longboard Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Longboard Pharmaceuticals Inc P/B ratio is 2.2394.
What is Longboard Pharmaceuticals Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Longboard Pharmaceuticals Inc's EBITDA is -7.09.
What is the 50-day moving average of Longboard Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Longboard Pharmaceuticals Inc 50-day moving average is $19.73.
How many employess does Longboard Pharmaceuticals Inc has?